The latest updates on thoughts, works, and stories
Welcome to the Southern edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
Welcome to the Western edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
Respiratory Diseases Influenza-like illness Finally, a reprieve. Influenza activity dropped, bringing welcome relief from what has been a long and intense season. Outpatient influenza-like illness (ILI), or the
Welcome to the Southern edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
Welcome to the Northeast edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
Welcome to the Midwestern edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
Welcome to the Western edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
Checking in on a particularly severe flu season
Welcome to the Southern edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
Welcome to the Midwestern edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
Welcome to the Northeast edition of Outbreak Outlook! It is only available to paid subscribers. If you wish to become a paid subscriber and access region-specific information, please click
I have a new article in the New York Times today challenging an under-appreciated point about America's vaccine debate. While most headlines focus on declining coverage and
